APPLIED THERAPEUTICS INC. - COMMON STOCK
0.5817
31-January-25 15:40:08
15 minutes delayed
Stocks
-0.0114
-1.92%
Today's range
0.5701 - 0.6199
ISIN
N/A
Source
NASDAQ
-
Applied Therapeutics Reports Second Quarter 2021 Financial Results
12 Aug 2021 07:00:02 By Nasdaq GlobeNewswire
-
Applied Therapeutics Added to Russell Microcap® Index
28 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
21 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Granted Fast Track Designation by FDA for AT-007 for Galactosemia
17 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
01 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Present at the UBS Global Healthcare Virtual Conference
19 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports First Quarter 2021 Financial Results
11 May 2021 07:00:02 By Nasdaq GlobeNewswire
-
Applied Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results
18 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Host Virtual Rare Disease Forum
16 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences
23 Feb 2021 07:00:01 By Nasdaq GlobeNewswire
-
Applied Therapeutics, Inc. Announces Closing of Public Offering
22 Feb 2021 07:00:00 By Nasdaq GlobeNewswire
-
Applied Therapeutics, Inc. Announces Pricing of Public Offering of 3,000,000 Shares of Common Stock
11 Feb 2021 18:51:34 By Nasdaq GlobeNewswire
-
Applied Therapeutics, Inc. Announces Offering of 3,000,000 Shares of Common Stock
10 Feb 2021 16:07:31 By Nasdaq GlobeNewswire
-
Applied Therapeutics Announces Restart of Pediatric Galactosemia Study
01 Feb 2021 07:00:00 By Nasdaq GlobeNewswire